Literature DB >> 16039063

Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie.

David A Kocisko1, Abbi L Engel, Kristin Harbuck, Kevin M Arnold, Emily A Olsen, Lynne D Raymond, Didier Vilette, Byron Caughey.   

Abstract

The transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases. A primary therapeutic target for TSE intervention has been a protease-resistant form of prion protein known as PrP(Sc) or PrP-res. In vitro testing of mouse scrapie-infected cell cultures has identified many PrP-res inhibitors that also have activity in vivo. Here we identify 32 new inhibitors of two strains of mouse scrapie PrP-res. Furthermore, to investigate the species-specificity of these and other PrP-res inhibitors, we have developed a high-throughput cell culture assay based on Rov9 cells chronically-infected with sheep scrapie. Of 32 inhibitors of murine PrP-res that were also tested in the Rov9 cells, only six showed inhibitory activity against sheep PrP-res. The three most potent inhibitors of both murine and ovine PrP-res formation (with 50% inhibition at < or =5 microM) were tannic acid, pentosan polysulfate and Fe(III) deuteroporphyrin 2,4-bisethyleneglycol. The latter two have anti-mouse scrapie activity in vivo. These results identify new inhibitors of murine and ovine PrP-res formation and reinforce the idea that compounds effective against PrP-res from one species or strain cannot be assumed to be active against others.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039063     DOI: 10.1016/j.neulet.2005.06.053

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

1.  Abrogation of complex glycosylation by swainsonine results in strain- and cell-specific inhibition of prion replication.

Authors:  Shawn Browning; Christopher A Baker; Emery Smith; Sukhvir P Mahal; Maria E Herva; Cheryl A Demczyk; Jiali Li; Charles Weissmann
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 2.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

3.  Inhibition of protease-resistant prion protein formation in a transformed deer cell line infected with chronic wasting disease.

Authors:  Gregory J Raymond; Emily A Olsen; Kil Sun Lee; Lynne D Raymond; P Kruger Bryant; Gerald S Baron; Winslow S Caughey; David A Kocisko; Linda E McHolland; Cynthia Favara; Jan P M Langeveld; Fred G van Zijderveld; Richard T Mayer; Michael W Miller; Elizabeth S Williams; Byron Caughey
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 4.  Biology and Genetics of PrP Prion Strains.

Authors:  Sina Ghaemmaghami
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

5.  A survey of antiprion compounds reveals the prevalence of non-PrP molecular targets.

Authors:  Guillaume Poncet-Montange; Susan J St Martin; Olga V Bogatova; Stanley B Prusiner; Brian K Shoichet; Sina Ghaemmaghami
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

6.  Diphenylpyrazole-derived compounds increase survival time of mice after prion infection.

Authors:  Fabienne Leidel; Martin Eiden; Markus Geissen; Hans A Kretzschmar; Armin Giese; Thomas Hirschberger; Paul Tavan; Hermann M Schätzl; Martin H Groschup
Journal:  Antimicrob Agents Chemother       Date:  2011-07-11       Impact factor: 5.191

Review 7.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

8.  meso-Tetra(pentafluorophenyl)porphyrin as an efficient platform for combinatorial synthesis and the selection of new photodynamic therapeutics using a cancer cell line.

Authors:  Diana Samaroo; Mikki Vinodu; Xin Chen; Charles Michael Drain
Journal:  J Comb Chem       Date:  2007-09-15

9.  Potent antiscrapie activities of degenerate phosphorothioate oligonucleotides.

Authors:  David A Kocisko; Andrew Vaillant; Kil Sun Lee; Kevin M Arnold; Nadine Bertholet; Richard E Race; Emily A Olsen; Jean-Marc Juteau; Byron Caughey
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

10.  Prion strain- and species-dependent effects of antiprion molecules in primary neuronal cultures.

Authors:  Sabrina Cronier; Vincent Beringue; Anne Bellon; Jean-Michel Peyrin; Hubert Laude
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.